2017Unpublished venueOpen access

0498 Biomarkers of concussion

V. Gallo, Damien McElvenny, Neil Pearce

Open full text 0 citations

Abstract

Concussion is a frequent occurrence in many contact sports and among soldiers, but also a possible inevitably consequence of accidents. Currently, the diagnosis of concussion is based on clinical symptoms, and it is difficult to predict prognosis. Biomarkers could be of invaluable help in informing the neuropathological events underlying concussive episodes. Specifically, they could contribute defining the diagnosis, the recovery process, and the long-term effect in presence or absence of chronic traumatic encephalopathy. For diagnosis and recovery, the neurofilaments and tau protein are promising biomarkers. No markers for CTE have been developed to date. The identification of biomarkers of diagnosis and recovery is particular important as most current research suggests that the risk of long-term symptoms following concussion is highest in individuals who have received repetitive concussions before the brain has recovered properly.

Open-access reader

About this research paper

What this paper is about

Concussion is a frequent occurrence in many contact sports and among soldiers, but also a possible inevitably consequence of accidents. Currently, the diagnosis of concussion is based on clinical symptoms, and it is difficult to predict prognosis. Biomarkers could be of invaluable help in informing the neuropathological events underlying concussive episodes. Specifically, they could contribute defining the diagnosis, the recovery process, and the long-term effect in presence or absence of chronic traumatic encephalopathy. For diagnosis and recovery, the neurofilaments and tau protein are promising biomarkers. No markers for CTE have been developed to date. The identification of biomarkers of diagnosis and recovery is particular important as most current research suggests that the risk of long-term symptoms following concussion is highest in individuals who have received repetitive concussions before the brain has recovered properly.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Concussion is a frequent occurrence in many contact sports and among soldiers, but also a possible inevitably consequence of accidents. Currently, the diagnosis of concussion is based on clinical symptoms, and it is difficult to predict prognosis. Biomarkers could be of invaluable help in informing the neuropathological events underlying concussive episodes. Specifically, they could contribute defining the diagnosis, the recovery process, and the long-term effect in presence or absence of chronic traumatic encephalopathy. For diagnosis and recovery, the neurofilaments and tau protein are promising biomarkers. No markers for CTE have been developed to date. The identification of biomarkers of diagnosis and recovery is particular important as most current research suggests that the risk of long-term symptoms following concussion is highest in individuals who have received repetitive concussions before the brain has recovered properly.

Key concepts: Concussion, Chronic traumatic encephalopathy, Medicine, Intensive care medicine, Encephalopathy, Poison control, Bioinformatics, Injury prevention

Related papers

Back to paper searchBrowse research topicsOriginal source
0498 Biomarkers of concussion — Research Paper | ScholarLens